| Literature DB >> 36174041 |
Mizuki Matsumoto1, Hirofumi Tsuru2,3, Hidehiro Suginobe2, Jun Narita2, Ryo Ishii2, Masaki Hirose2, Kazuhisa Hashimoto2, Renjie Wang2, Chika Yoshihara2, Atsuko Ueyama2, Ryosuke Tanaka1, Keiichi Ozono2, Takaharu Okajima1, Hidekazu Ishida2.
Abstract
Restrictive cardiomyopathy (RCM) is a rare disease characterized by increased ventricular stiffness and preserved ventricular contraction. Various sarcomere gene variants are known to cause RCM; however, more than a half of patients do not harbor such pathogenic variants. We recently demonstrated that cardiac fibroblasts (CFs) play important roles in inhibiting the diastolic function of cardiomyocytes via humoral factors and direct cell-cell contact regardless of sarcomere gene mutations. However, the mechanical properties of CFs that are crucial for intercellular communication and the cardiomyocyte microenvironment remain less understood. In this study, we evaluated the rheological properties of CFs derived from pediatric patients with RCM and healthy control CFs via atomic force microscopy. Then, we estimated the cellular modulus scale factor related to the cell stiffness, fluidity, and Newtonian viscosity of single cells based on the single power-law rheology model and analyzed the comprehensive gene expression profiles via RNA-sequencing. RCM-derived CFs showed significantly higher stiffness and viscosity and lower fluidity compared to healthy control CFs. Furthermore, RNA-sequencing revealed that the signaling pathways associated with cytoskeleton elements were affected in RCM CFs; specifically, cytoskeletal actin-associated genes (ACTN1, ACTA2, and PALLD) were highly expressed in RCM CFs, whereas several tubulin genes (TUBB3, TUBB, TUBA1C, and TUBA1B) were down-regulated. These results implies that the signaling pathways associated with cytoskeletal elements alter the rheological properties of RCM CFs, particularly those related to CF-cardiomyocyte interactions, thereby leading to diastolic cardiac dysfunction in RCM.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36174041 PMCID: PMC9522286 DOI: 10.1371/journal.pone.0275296
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Frequency-domain AFM measurement of cardiac fibroblasts (CFs).
(A) Modulated voltages with n frequencies from f = f1 to fn were added and applied to the z-scanner to oscillate the cantilever. The amplitude A(f) and phase shift θ(f) of the cantilever deflection signal at each frequency during the indentation were calculated with a multiple lock-in amplifier program and used to estimate the storage G’ and loss G” moduli as a function of f at each measurement position. The frequency dependences of geometric mean and standard deviation of G’ and G” of all cells derived from three patients with RCM (B, n = 165 cells) and three healthy controls (C, n = 63 cells). Solid lines represent the fitted results to Eq 3.
Clinical characteristics of patients.
| RCM 1 | RCM 2 | RCM 3 | |
|---|---|---|---|
|
| Male | Male | Female |
|
| 2 years | 6 years | 8 months |
|
| 3 years | 11 years | 2 years |
|
| LVAD | LVAD | HTx |
|
| 24 mmHg | 24 mmHg | 25 mmHg |
|
| Dobutamine | Milrinone | LVAD |
| Milrinone | Diuretics | Dobutamine | |
| Diuretics | ACE inhibitor | Milrinone | |
| Beta-blocker | Amiodarone | Diuretics | |
| Aspirin | Aspirin | Warfarin | |
|
| 568.8 pg/mL | 2577.5 pg/mL | 949.7 pg/mL |
|
| Not detected |
LVEDP, left ventricular end diastolic pressure; BNP, brain natriuretic peptide; LVAD, left ventricular assist device; HTx, heart transplantation; ACE, angiotensin-converting enzyme.
Fig 2Quantification of power-law rheological parameters of the cardiac fibroblasts (CFs).
(A) The cell modulus scale factor, G0, (B) the power-law exponent, α, and (C) the Newtonian viscous damping coefficient, μ, in CFs derived from patients with restrictive cardiomyopathy (RCM, n = 3) and healthy controls (hCF, n = 3). Data are presented as mean ± standard deviation. *P < 0.05 by unpaired two-tailed t-test.
Fig 3RNA-sequencing analyses of cardiac fibroblasts (CFs).
(A) Hierarchical clustering of top 1000 genes between restrictive cardiomyopathy (RCM) and healthy control CFs (hCF). (B) K-means clustering of RCM CFs and hCFs. (C) Pathway analyses of K-means clustering indicate that actin filament-associated processes and anatomical structure morphogenesis are affected in RCM CFs. (D) Differential gene expression analysis revealed that expression levels of several genes associated with the cytoskeleton and cell adhesion are significantly up- or down-regulated in RCM CFs.
Fig 4Immunocytochemistry of cellular cytoskeletal components in cardiac fibroblasts (CFs).
Representative images of immunocytochemistry for actin filaments (phalloidin) and tubulin in RCM CFs and healthy CFs. The numbers represent the individuals. Scale bar: 50 μm.